Clinical trialPhase 2Withdrawn
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
Phase II Study of Adjuvant Gemcitabine Started One Week After Laparoscopic
- Outcome
- Stopped earlyThe study was never initiated (Other)
- Phase
- Phase 2
- Status
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 participants
- Sites
- 1
- Primary outcomes
- To determine if it is safe to administer gemcitabine to patients with pancreatic cancer one week after laparoscopic distal pancreatectomy.
- Sponsor
- Other
- Results posted
- No
- Last update
- 6 October 2016
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try